Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Piramal Enterprises Ltd    PEL   INE140A01024

End-of-day quote. End-of-day quote  - 05/26
2734 INR   +1.37%
05/26 EQUITAS : Open interest losers on Friday
05/15 Open interest gainers on Monday
05/15 PIRAMAL ENTERPR : stock spikes 10% on good Q4 earnings
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
05/22/2017 05/23/2017 05/24/2017 05/25/2017 05/26/2017 Date
2771(c) 2736(c) 2647(c) 2697(c) 2734 Last
241 696 271 260 322 195 307 960 307 960 Volume
-2.22% -1.26% -3.25% +1.89% +1.37% Change
More quotes
Financials ( INR)
Sales 2018 103 020 M
EBIT 2018 30 786 M
Net income 2018 -
Debt 2018 70 946 M
Yield 2018 0,97%
Sales 2019 135 288 M
EBIT 2019 46 210 M
Net income 2019 -
Debt 2019 -
Yield 2019 2,09%
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 5,26x
Capi. / Sales2019 3,48x
Capitalization 470 752 M
More Financials
Company
Piramal Enterprises Ltd. engages in pharmaceutical business with its research and development activities.The company operates through the following segments: Piramal Healthcare, Piramal Capital and Information Management.The Piramal Healthcare segment operates through the following divisions:... 
More about the company
Latest news on PIRAMAL ENTERPRISES LTD
05/26 EQUITAS : Open interest losers on Friday
05/15 Open interest gainers on Monday
05/15 PIRAMAL ENTERPRISES : stock spikes 10% on good Q4 earnings
05/14 PIRAMAL ENTERPRISES : announces dividend
05/13 PIRAMAL ENTERPRISES : TO RAISE UP TO Rs5,000 CRORE
05/12 PIRAMAL ENTERPRISES : Announces Consolidated Results for Q4 FY2017 and FY2017
05/11 PIRAMAL ENTERPRISES : Patent Application Titled "Pharmaceutical Combination for ..
05/10 PIRAMAL PLANS TO RAISE UP TO Rs4,000 CRORE VIA QIP
05/09PIRAMAL ENTERPRISES LTD : annual earnings release
04/27 PIRAMAL ENTERPRISES : Introduces ‘Paan’ flavour for its Leading Anta..
More news
Sector news : Pharmaceuticals - NEC
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
Latest Tweets
05/23Piramal Enterprises eyeing rural market for OTC products
3
05/15Piramal Enterprises shares surge 10% on good Q4 show  
05/15Piramal Enterprises Surges Over 13%, Hits 52-Week High On Q4 Earnings
1
05/15#BuzzingStock: Piramal Enterprises soars 8% after strong Q4 results
2
05/13Piramal Enterprises stock up nearly 3 per cent after Q4 earnings
1
More tweets
Qtime:15
Advertisement
Chart PIRAMAL ENTERPRISES LTD
Duration : Period :
Piramal Enterprises Ltd Technical Analysis Chart | PEL | INE140A01024 | 4-Traders
Full-screen chart
Technical analysis trends PIRAMAL ENTERPRIS...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 2 028  INR
Spread / Average Target -26%
Consensus details
Managers
NameTitle
Ajay Gopikisan Piramal Chairman
Vijay Kantilal Shah Chief Operating Officer & Executive Director
Rajesh R. Laddha Chief Financial Officer
Swati Ajay Piramal Vice Chairman
Subramanian V. Ramadorai Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PIRAMAL ENTERPRISES LT..66.48%7 298
JOHNSON & JOHNSON10.69%341 901
ROCHE HOLDING LTD.14.88%236 581
NOVARTIS AG6.75%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results